Haukeland University Hospital is a hospital in Bergen, Norway, and one of the eleven institutions that make up Bergen Hospital Trust.

There are 1,100 beds in Department of Heart Disease, Haukeland University Hospital.

During the past decade, Department of Heart Disease, Haukeland University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Heart Disease, Haukeland University Hospital" #1 collaborator was "Haukeland University Hospital" with 2 trials as a collaborator, "Norwegian Foundation for Health and Rehabilitation" with 2 trials as a collaborator, "The Research Council of Norway" with 2 trials as a collaborator, "The Royal Norwegian Ministry of Health" with 2 trials as a collaborator and "Alpharma Pharmaceuticals LLC, a subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Department of Heart Disease, Haukeland University Hospital" are "Myocardial Infarction" (3 trials), "Cerebrovascular Stroke" (2 trials), "Coronary Atherosclerosis" (2 trials), "Angina Pectoris" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Department of Heart Disease, Haukeland University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Heart Disease, Haukeland University Hospital" are "Device" (2 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active fixation bipolar lead versus passive fixation quadripolar leads in Cardiac Resynchronization Therapy" (1 trials), "Percutaneous coronary intervention (PCI)" (1 trials), "Perflutren Lipid Microsphere ultrasound contrast" (1 trials), "There is no intervention" (1 trials) and "folic acid, vitamin B12 (cyanocobalamin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Heart Disease, Haukeland University Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Department of Heart Disease, Haukeland University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Department of Heart Disease, Haukeland University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Heart Disease, Haukeland University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".